Q2 2025 Earnings Call Transcript February 6, 2025 Synaptics Incorporated beats earnings expectations. Reported EPS is $0.92, ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

David Maura; Executive Chairman of the Board, Chief Executive Officer; Spectrum Brands Holdings Inc Jeremy Smeltser; Chief Financial Officer, Executive Vice President; Spectrum Brands Holdings Inc ...